Active, not recruitingNCT05168631
Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
Studying Embryonal carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Latin American Cooperative Oncology Group
- Enrollment
- 88 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2025
Study locations (7)
- Universidade Federal do Ceará/HOSPITAL UNIVERSITARIO WALTER CANTIDIO, Fortaleza, Ceará, Brazil
- Ensino E Terapia de Inovacao Clinica Amo - Etica, Salvador, Estado de Bahia, Brazil
- Hospital Sírio Libanês Brasília, Brasília, Federal District, Brazil
- Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil
- Fundacao Antonio Prudente - Ac Camargo Center, São Paulo, Brazil
- Hospital Alemão Oswaldo Cruz, São Paulo, Brazil
- Instituto Nacional de Enfermedades Neoplàsicas, Surquillo, Peru
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05168631 on ClinicalTrials.govOther trials for Embryonal carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT04086485Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)National Cancer Institute (NCI)
- RECRUITINGNCT02688894The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]Samsung Medical Center
- RECRUITINGPHASE1, PHASE2NCT02174549Dose-defining Study of Tirapazamine Combined With Embolization in Liver CancerTeclison Ltd.
- RECRUITINGNANCT01980264Harmonics-based in Vivo Optical Virtual BiopsyNational Taiwan University Hospital